default author photo

Jianming Cai

Government of the People's Republic of China - Department of Radiology

China

  • Government of the People's Republic of China - Department of Radiology

SCHOLARLY PAPERS

3

DOWNLOADS

221

TOTAL CITATIONS

3

Scholarly Papers (3)

Actions:
Email selected abstracts
1.

Deep Learning Model for Automated Diagnosis of Moyamoya Disease Based on Magnetic Resonance Angiography

Number of pages: 31 Posted: 28 Jun 2024
Mingming Lu, Yijia Zheng, Shitong Liu, Xiaolan Zhang, Jiahui Lv, Yuan Liu, Baobao Li, Fei Yuan, Peng Peng, Cong Han, Chune Ma, Chao Zheng, Hongtao Zhang and Jianming Cai
Chinese People’s Armed Police Force, Tsinghua University, Government of the People's Republic of China - Chinese PLA General Hospital, Shukun Technology Co. Ltd., Shukun Technology Co. Ltd., Government of the People's Republic of China - Chinese PLA General Hospital, Academy of Military Sciences - State Key Laboratory of Pathogen and Biosecurity, Chinese People’s Armed Police Force, Chinese People’s Armed Police Force, Government of the People's Republic of China - Department of Neurosurgery, Shukun Technology Co. Ltd., Shukun Technology Co. Ltd., Government of the People's Republic of China - Chinese PLA General Hospital and Government of the People's Republic of China - Department of Radiology
Downloads 79 (816,709)
Citation 1

Abstract:

Loading...

Artificial Intelligence, Convolutional Neural Network, Automated Diagnosis, Moyamoya Disease

2.

Human Umbilical Cord-Derived Mesenchymal Stem Cell Treatment for Severe COVID-19: 3-Year Follow-Up of a Randomized, Double Blind, Placebo-Controlled Trial

Number of pages: 26 Posted: 17 Jan 2024
Meng-Qi Yuan, Le Song, Ze-Rui Wang, Zi-Ying Zhang, Ming Shi, Junli He, Qiong Mo, Ning Zheng, Weiqi Yao, Yu Zhang, Tengyun Dong, Yuanyuan Li, Chao Zhang, Jinwen Song, Lei Huang, Zhe Xu, Xin Yuan, Jun-Liang Fu, Cheng Zhen, Jianming Cai, Jinghui Dong, Jianzeng Zhang, Wei-fen Xie, Yonggang Li, Bo Zhang, Lei Shi and Fu-Sheng Wang
Government of the People's Republic of China - Chinese PLA General Hospital, Government of the People's Republic of China - Chinese PLA General Hospital, Government of the People's Republic of China - Chinese PLA General Hospital, Government of the People's Republic of China - Chinese PLA General Hospital, Government of the People's Republic of China - Treatment and Research Center for Infectious Diseases, Government of the People's Republic of China - Chinese PLA General Hospital, Government of the People's Republic of China - Chinese PLA General Hospital, Government of the People's Republic of China - Chinese PLA General Hospital, Wuhan Optics Valley Vcanbio Cell & Gene Technology Co., Ltd., Wuhan Optics Valley Vcanbio Cell & Gene Technology Co., Ltd., Wuhan Optics Valley Vcanbio Cell & Gene Technology Co., Ltd., Government of the People's Republic of China - Chinese PLA General Hospital, Government of the People's Republic of China - Treatment and Research Center for Infectious Diseases, Government of the People's Republic of China - Chinese PLA General Hospital, Government of the People's Republic of China - Chinese PLA General Hospital, Government of the People's Republic of China - Chinese PLA General Hospital, Government of the People's Republic of China - Chinese PLA General Hospital, Chinese PLA General - Department of Infectious Diseases, Government of the People's Republic of China - Chinese PLA General Hospital, Government of the People's Republic of China - Department of Radiology, Government of the People's Republic of China - Department of Radiology, Wuhan Optics Valley Vcanbio Cell & Gene Technology Co., Ltd., Government of the People's Republic of China - Department of Gastroenterology, Government of the People's Republic of China - Chinese PLA General Hospital, Government of the People's Republic of China - Chinese PLA General Hospital, Government of the People's Republic of China - Department of Infectious Diseases and Government of the People's Republic of China - Treatment and Research Center for Infectious Diseases
Downloads 76 (860,052)

Abstract:

Loading...

Keywords：COVID-19, Mesenchymal stem cell Therapy, 3-year follow-up, Long-COVID

3.

Human Mesenchymal Stem Cells Treatment for Severe COVID-19: 1-Year Follow-Up Results of a Randomized, Double-Blind, Placebo-Controlled Trial

Number of pages: 35 Posted: 28 Jul 2021
Lei Shi, Xin Yuan, Wei Qi Yao, Siyu Wang, Chao Zhang, Bo Zhang, Jinwen Song, Lei Huang, Zhe Xu, Jun-Liang Fu, Yuanyuan Li, Ruonan Xu, Tian-Tian Li, Jinghui Dong, Jianming Cai, Genshi Li, Yunbo Xie, Ming Shi, Yonggang Li, Yu Zhang, Wei-fen Xie and Fu-Sheng Wang
Government of the People's Republic of China - Treatment and Research Center for Infectious Diseases, Government of the People's Republic of China - Treatment and Research Center for Infectious Diseases, Huazhong University of Science and Technology - Department of Hematology, Government of the People's Republic of China - Treatment and Research Center for Infectious Diseases, Government of the People's Republic of China - Treatment and Research Center for Infectious Diseases, Government of the People's Republic of China -Department of Infectious Disease, Government of the People's Republic of China - Treatment and Research Center for Infectious Diseases, Government of the People's Republic of China - Treatment and Research Center for Infectious Diseases, Government of the People's Republic of China - Treatment and Research Center for Infectious Diseases, Chinese PLA General - Department of Infectious Diseases, Government of the People's Republic of China - Treatment and Research Center for Infectious Diseases, Government of the People's Republic of China - Treatment and Research Center for Infectious Diseases, Government of the People's Republic of China - Treatment and Research Center for Infectious Diseases, Government of the People's Republic of China - Department of Radiology, Government of the People's Republic of China - Department of Radiology, Wuhan Kingmed Center for Clinical Laboratory Co., Ltd., Government of the People's Republic of China - Treatment and Research Center for Infectious Diseases, Government of the People's Republic of China - Treatment and Research Center for Infectious Diseases, Government of the People's Republic of China - Treatment and Research Center for Infectious Diseases, National Industrial Base for Stem Cell Engineering Products, Government of the People's Republic of China - Department of Gastroenterology and Government of the People's Republic of China - Treatment and Research Center for Infectious Diseases
Downloads 66 (916,100)
Citation 2

Abstract:

Loading...